Su-Han Jin

Department of Orthodontics

H指数:14

被引数:470

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RNA editing as an epitranscriptomic immune switch in tumor immunity and cancer immunotherapy

RNA编辑作为肿瘤免疫和癌症免疫治疗中的表观转录组免疫开关

Journal of Translational Medicine

IF7.5

2026-10-230

OAAI

First-line immune checkpoint inhibitors versus chemotherapy in delaying quality of life deterioration in advanced NSCLC: a systematic review and meta-analysis

一线免疫检查点抑制剂与化疗在延缓晚期非小细胞肺癌生活质量恶化方面的比较：一项系统评价和荟萃分析

BMC Medicine

IF8.3

2026-08-140

CircRNA signature predicts immunotherapy response in advanced non-small cell lung cancer

环状RNA特征预测晚期非小细胞肺癌的免疫治疗反应

Therapeutic Advances in Medical Oncology

IF4.2

2025-11-250

Human Endogenous Retroviruses and Diseases

人类内源性逆转录病毒与疾病

MedComm

IF10.7

2025-11-020

OAAI

Association between pretreatment emotional distress and survival outcomes in patients with advanced non–small-cell lung cancer: an individual patient data meta-analysis of 4632 patients in seven trials

治疗前情绪困扰与晚期非小细胞肺癌患者生存结局的关联：一项基于七项试验4632例患者的个体患者数据Meta分析

Therapeutic Advances in Medical Oncology

IF4.2

2025-09-160

β-catenin is a Potential Prognostic Biomarker in Uterine Sarcoma

β-catenin是子宫肉瘤的一个潜在预后生物标志物。

TECHNOLOGY IN CANCER RESEARCH & TREATMENT

IF2.8

2025-05-210

Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma

单细胞rna-seq揭示FGF12作为低级别子宫内膜间质肉瘤的预后生物标志物

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-11-290

OAAI

Spatial Transcriptomics Identifies Novel Clinical Markers to Classify the Etiology of Rare and Aggressive Cardiac Sarcomas

空间转录组学识别新型临床标志物以分类罕见且侵袭性心脏肉瘤的病因

CIRCULATION

IF38.6

2024-11-120

PRE

The signaling pathways involved in non-coding RNA regulation during osteogenic differentiation of periodontal tissue-derived cells in the field of periodontitis

JOURNAL OF PERIODONTAL RESEARCH

IF3.4

2023-11-141

Identification of immunological bioprocesses involved in peri-implantitis using weighted gene co-expression network analysis

JOURNAL OF PERIODONTOLOGY

IF3.8

2023-04-303

PRE

Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients-Knowledge from two independent international studies

NEOPLASIA

IF7.7

2023-03-013

OAAI

Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2022-09-242

OAAI

Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-09-020

OAAI

Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-06-3012

OAAI

Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy

鉴定15个lncRNAs签名预测Anti-PD-1单药治疗晚期黑色素瘤患者的生存获益

CELLS

IF5.2

2021-04-2231

OAAI

Co-expression gene modules involved in cisplatin-induced peripheral neuropathy according to sensitivity, status, and severity

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

IF3.2

2020-09-043

PREAI

Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors

FRONTIERS IN ONCOLOGY

IF3.3

2020-07-301

OAAI

Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials

ESMO OPEN

IF8.3

2020-01-0118

OAAI

Influence of marital status on overall survival in patients with ovarian serous carcinoma: finding from the surveillance epidemiology and end results (SEER) database

JOURNAL OF OVARIAN RESEARCH

IF4.2

2019-12-3024

OAAI

Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma

FRONTIERS IN ONCOLOGY

IF3.3

2019-12-0426

OAAI

Su-Han Jin

个人简介

教育背景

工作经历

荣誉奖项

研究方向